Chartwell Investment Partners’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,835
Closed -$259K 439
2024
Q1
$259K Buy
+6,835
New +$259K 0.01% 406